Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenergic Neurons: Neurotransmission01:27

Adrenergic Neurons: Neurotransmission

5.1K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
5.1K
Postsynaptic Potential (PSP)01:32

Postsynaptic Potential (PSP)

4.8K
Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
4.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treating depression through G proteins.

Science signaling·2026
Same author

Sense and stromal density.

Science signaling·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

In Science Journals.

Science (New York, N.Y.)·2026
Same author

Skewing p53 to tumor-suppressor targets.

Science signaling·2025
Same author

<i>APOE</i> ε4 on immunity.

Science signaling·2025
Same journal

ZNRF3 and RNF43 are active monomeric E3 ubiquitin ligases that self-associate.

Science signaling·2026
Same journal

Allosteric ligands with distinct properties uncover tissue-specific physiological regulation mediated by free fatty acid receptor 2.

Science signaling·2026
Same journal

Diacylglycerol kinase ζ in B lymphocytes supports CD40-mediated immune synapse formation, mTORC1 signaling, and plasma cell fate.

Science signaling·2026
Same journal

The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma.

Science signaling·2026
Same journal

Fattening mother's milk with oxytocin.

Science signaling·2026
Same journal

Virion display reveals MD-1 as an endogenous agonist for the orphan receptor GPRC5B.

Science signaling·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.5K

Neuron-tumor synapses drive PDAC.

Leslie K Ferrarelli1

  • 1Science Signaling, AAAS, Washington, DC 20005, USA.

Science Signaling
|January 13, 2026
PubMed
Summary
This summary is machine-generated.

Neurons form synapses with pancreatic tumor cells, driving cancer growth through glutamate signaling. This feedforward loop promotes oncogenic pathways, highlighting a novel therapeutic target.

More Related Videos

Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons
06:54

Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons

Published on: September 9, 2020

6.7K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 15, 2026

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.5K
Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons
06:54

Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons

Published on: September 9, 2020

6.7K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.3K

Area of Science:

  • Neuroscience
  • Oncology
  • Cell Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy.
  • Tumor microenvironments are complex and involve interactions between cancer cells and surrounding tissues.
  • Neuronal involvement in cancer progression is an emerging area of research.

Purpose of the Study:

  • To investigate the functional role of synapses between neurons and pancreatic tumor cells.
  • To elucidate the signaling pathways mediated by these neuron-tumor cell interactions.
  • To determine the impact of this signaling on pancreatic cancer progression.

Main Methods:

  • Immunohistochemistry and high-resolution imaging to identify neuronal infiltration in PDAC.
  • Electrophysiological recordings to detect synaptic activity between neurons and tumor cells.
  • Molecular analyses to identify key signaling molecules, including glutamate receptors.
  • In vivo and in vitro models of PDAC to assess the functional consequences of neuron-tumor cell signaling.

Main Results:

  • Synaptic structures were identified at the interface of neurons and PDAC cells.
  • Neuron-derived glutamate release was detected, activating tumor cell glutamate receptors.
  • This glutamatergic signaling promoted tumor cell proliferation, migration, and invasion.
  • Inhibition of glutamate signaling pathways suppressed tumor growth in preclinical models.

Conclusions:

  • Synapses between neurons and pancreatic tumor cells represent a novel mechanism of oncogenic signaling.
  • Targeting neuron-tumor cell communication offers a potential therapeutic strategy for PDAC.
  • Understanding these interactions is crucial for developing effective treatments for pancreatic cancer.